1-4 of 4
Barbara Dietrich, DVM
Close
Sort by
Journal Articles

Preclinical Safety of Baxter's Recombinant ADAMTS13

Christina Piskernik, DVM, Barbara Dietrich, DVM, Susan Kubik, BSc, Tanja Ruthsatz, DVM, Friedrich Scheiflinger, PhD, Hans Peter Schwarz, MD, Eva-Maria Muchitsch, DVM
Journal: Blood
Blood (2012) 120 (21): 3381.
https://doi.org/10.1182/blood.V120.21.3381.3381
Published: 2012
Journal Articles

Safety of Baxter’s Longer Acting rFVIII (BAX 855) After Repeated Application in Rats and Cynomolgus Monkeys

Barbara Dietrich, DVM, Margit Spatzenegger, PhD, Reinhard Stidl, PhD, Martin Wolfsegger, PhD, Hartmut J. Ehrlich, MD, Friedrich Scheiflinger, PhD, Hans Peter Schwarz, MD, Eva-Maria Muchitsch
Journal: Blood
Blood (2011) 118 (21): 4345.
https://doi.org/10.1182/blood.V118.21.4345.4345
Published: 2011
Journal Articles

Preclinical Safety Pharmacology of Baxter’s Longer Acting rFVIII (BAX 855)

Barbara Dietrich, DVM, Susan Kubik, BSc, Hartmut J. Ehrlich, MD, Friedrich Scheiflinger, PhD, Hans Peter Schwarz, MD, Eva-Maria Muchitsch
Journal: Blood
Blood (2011) 118 (21): 4357.
https://doi.org/10.1182/blood.V118.21.4357.4357
Published: 2011
Journal Articles

Absorption, Metabolism, Distribution, and Excretion of Longer Acting rFVIII (BAX 855) Following Intravenous Administration to Rats

Reinhard Stidl, PhD, Juergen Siekmann, PhD, Sean M Culbertson, Tony Vinson, Antoni Kozlowski, Xiaoming Shen, Mary J Bossard, Hanspeter Rottensteiner, PhD, Barbara Dietrich, DVM, Chyung Cook, Peter L Turecek, PhD, Hartmut J. Ehrlich, MD, Friedrich Scheiflinger, PhD, Hans Peter Schwarz, MD, Eva-Maria Muchitsch
Journal: Blood
Blood (2011) 118 (21): 4358.
https://doi.org/10.1182/blood.V118.21.4358.4358
Published: 2011